News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
674,593 Results
Type
Article (57466)
Company Profile (222)
Press Release (616904)
Multimedia
Podcasts (114)
Webinars (17)
Section
Business (191680)
Career Advice (2687)
Deals (34562)
Drug Delivery (122)
Drug Development (79632)
Employer Resources (190)
FDA (16578)
Job Trends (13974)
News (331101)
Policy (33783)
Tag
Academia (2535)
Academic (1)
Accelerated approval (14)
Adcomms (33)
Allergies (100)
Alliances (44730)
ALS (115)
Alzheimer's disease (1582)
Antibody-drug conjugate (ADC) (182)
Approvals (16526)
Artificial intelligence (342)
Autoimmune disease (38)
Automation (17)
Bankruptcy (356)
Best Places to Work (10541)
BIOSECURE Act (22)
Biosimilars (133)
Biotechnology (165)
Bladder cancer (101)
Brain cancer (38)
Breast cancer (383)
Cancer (3034)
Cardiovascular disease (246)
Career advice (2249)
Career pathing (33)
CAR-T (209)
CDC (43)
Cell therapy (558)
Cervical cancer (23)
Clinical research (65539)
Collaboration (1064)
Company closure (3)
Compensation (733)
Complete response letters (39)
COVID-19 (2815)
CRISPR (67)
C-suite (365)
Cystic fibrosis (117)
Data (3111)
Decentralized trials (2)
Denatured (25)
Depression (81)
Diabetes (356)
Diagnostics (6079)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (49)
Drug discovery (153)
Drug pricing (151)
Drug shortages (33)
Duchenne muscular dystrophy (157)
Earnings (85896)
Editorial (50)
Employer branding (24)
Employer resources (162)
Events (98393)
Executive appointments (862)
FDA (18386)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (922)
Gene editing (145)
Generative AI (30)
Gene therapy (442)
GLP-1 (919)
Government (4645)
Grass and pollen (7)
Guidances (219)
Healthcare (17031)
HIV (43)
Huntington's disease (32)
IgA nephropathy (42)
Immunology and inflammation (191)
Immuno-oncology (13)
Indications (38)
Infectious disease (3011)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (74)
Intellectual property (125)
Interviews (492)
IPO (16883)
IRA (54)
Job creations (3798)
Job search strategy (1882)
Kidney cancer (14)
Labor market (60)
Layoffs (585)
Leadership (26)
Legal (8079)
Liver cancer (81)
Longevity (12)
Lung cancer (419)
Lymphoma (214)
Machine learning (12)
Management (61)
Manufacturing (446)
MASH (102)
Medical device (12454)
Medtech (12458)
Mergers & acquisitions (18440)
Metabolic disorders (935)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (150)
Neuropsychiatric disorders (45)
Neuroscience (2333)
NextGen: Class of 2025 (5768)
Non-profit (3670)
Now hiring (51)
Obesity (487)
Opinion (276)
Ovarian cancer (104)
Pain (124)
Pancreatic cancer (130)
Parkinson's disease (196)
Partnered (22)
Patents (329)
Patient recruitment (178)
Peanut (52)
People (53052)
Pharmaceutical (46)
Pharmacy benefit managers (25)
Phase I (20140)
Phase II (28707)
Phase III (22163)
Pipeline (1750)
Policy (246)
Postmarket research (2608)
Preclinical (8395)
Press Release (66)
Prostate cancer (151)
Psychedelics (45)
Radiopharmaceuticals (259)
Rare diseases (520)
Real estate (5402)
Recruiting (72)
Regulatory (23860)
Reports (62)
Research institute (2296)
Resumes & cover letters (433)
Rett syndrome (10)
RNA editing (12)
RSV (57)
Schizophrenia (100)
Series A (162)
Series B (115)
Service/supplier (12)
Sickle cell disease (65)
Special edition (22)
Spinal muscular atrophy (154)
Sponsored (36)
Startups (3447)
State (1)
Stomach cancer (17)
Supply chain (81)
Tariffs (71)
The Weekly (88)
Vaccines (921)
Venture capital (59)
Weight loss (329)
Women's health (44)
Worklife (20)
Date
Last 7 days (522)
Last 30 days (1765)
Last 365 days (31095)
2025 (18283)
2024 (34915)
2023 (39433)
2022 (50550)
2021 (54440)
2020 (51590)
2019 (42407)
2018 (32206)
2017 (33015)
2016 (31720)
2015 (35933)
2014 (30778)
2013 (26560)
2012 (26455)
2011 (26972)
2010 (25131)
Location
Africa (856)
Alabama (63)
Alaska (6)
Arizona (210)
Arkansas (12)
Asia (40471)
Australia (6849)
California (7538)
Canada (2221)
China (662)
Colorado (305)
Connecticut (342)
Delaware (207)
Europe (94590)
Florida (1149)
Georgia (238)
Hawaii (3)
Idaho (55)
Illinois (623)
India (28)
Indiana (360)
Iowa (18)
Japan (239)
Kansas (103)
Kentucky (21)
Louisiana (15)
Maine (67)
Maryland (1079)
Massachusetts (5699)
Michigan (239)
Minnesota (466)
Mississippi (3)
Missouri (88)
Montana (21)
Nebraska (21)
Nevada (81)
New Hampshire (68)
New Jersey (2134)
New Mexico (22)
New York (2090)
North Carolina (1109)
North Dakota (9)
Northern California (3336)
Ohio (222)
Oklahoma (12)
Oregon (33)
Pennsylvania (1601)
Puerto Rico (12)
Rhode Island (28)
South America (1210)
South Carolina (35)
South Dakota (1)
Southern California (2850)
Tennessee (119)
Texas (1128)
United States (27903)
Utah (209)
Virginia (186)
Washington D.C. (69)
Washington State (631)
West Virginia (4)
Wisconsin (72)
674,593 Results for "wong s biotech stock report".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capitalists
More Than One-Third of Biotechs Have Under a Year of Cash Left, EY Finds
EY’s 2025 Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies facing cash runways of less than one year. The analyst firm’s leaders urge a return to basics for biotech.
June 18, 2025
·
4 min read
·
Ana Mulero
NextGen
In Biotech’s ‘Moribund’ Market, What Does It Take To Survive?
BioSpace
’s NextGen companies are rising in one of the most confounding biotech markets ever experienced. Executives sounded off on how to keep your head above water during our webinar,
Are We There Yet?
May 21, 2025
·
6 min read
·
Annalee Armstrong
Earnings
Q2 2025: Biotechs To Watch For This Earnings Season
Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched biotechs fare?
July 24, 2025
·
10 min read
·
Tristan Manalac
Press Releases
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025
July 28, 2025
·
10 min read
Tariffs
Biotech’s ‘Nauseating Roller Coaster’ Repels Investors
Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty sent fresh shockwaves through an already fragile market.
April 23, 2025
·
5 min read
·
Ana Mulero
Press Releases
Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET
June 26, 2025
·
2 min read
Press Releases
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025
July 30, 2025
·
1 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q2 2025
The life sciences job market continues to shift.
BioSpace
’s Q2 2025 U.S. Life Sciences Job Market Report is now available, offering exclusive insights into the latest hiring trends, layoffs, and workforce dynamics across the life sciences industry.
July 17, 2025
·
1 min read
·
BioSpace Insights
FDA
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and the accelerated approval of cancer drugs.
May 6, 2025
·
3 min read
·
Heather McKenzie
Tariffs
Biotech’s Next Phase Will Be All-American: Pitchbook
With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.
April 17, 2025
·
2 min read
·
Annalee Armstrong
1 of 67,460
Next
